Christy Fischer has never felt lost or sorry for herself during the 18 years since her diagnosis with stage IV lung cancer.

In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

Globally, the prevalence of adolescents experiencing symptoms of anxiety and depression has been rising steeply in the past two decades,1 and diagnoses continue to increase.2 Symptoms of anxiety and ...

Building on the evidence from the first paper in this Series highlighting the fundamental importance of healthy and nurturing ...

The UN has declared November 24 as World Conjoined Twins Day,1 an initiative led by Saudi Arabia to raise global awareness about the medical and societal challenges faced by conjoined twins and their ...

I have had Parkinson's [disease] for about 10 years now”, says Ian Temple, an ambassador for and dancer with Dance for ...

The centrality of the first 1000 days—from conception to 2 years of age—for early childhood development is recognised in ...

The long-awaited therapeutic pipeline for Crohn's disease is now coming to fruition, with the emergence of novel drug classes offering hope for our patients. Yet despite increasing options, treatment ...

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar ...

In a global landscape defined by polycrisis, children are being failed. To address this failure, we ask an ambitious yet ...